Corneal injury: Clinical and molecular aspects
- PMID: 31238077
- PMCID: PMC6703935
- DOI: 10.1016/j.exer.2019.107709
Corneal injury: Clinical and molecular aspects
Abstract
Currently, over 10 million people worldwide are affected by corneal blindness. Corneal trauma and disease can cause irreversible distortions to the normal structure and physiology of the cornea often leading to corneal transplantation. However, donors are in short supply and risk of rejection is an ever-present concern. Although significant progress has been made in recent years, the wound healing cascade remains complex and not fully understood. Tissue engineering and regenerative medicine are currently at the apex of investigation in the pursuit of novel corneal therapeutics. This review uniquely integrates the clinical and cellular aspects of both corneal trauma and disease and provides a comprehensive view of the most recent findings and potential therapeutics aimed at restoring corneal homeostasis.
Keywords: Corneal trauma; Diabetic keratopathy; Fuchs' dystrophy; Keratoconus; Regenerative medicine.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflicts of Interest
The authors declare that no conflict of interest exists.
Figures
References
-
- Abdelkader H, Patel DV, McGhee CNj, and Alany RG 2011. ‘New therapeutic approaches in the treatment of diabetic keratopathy: a review’, Clin Exp Ophthalmol, 39: 259–70. - PubMed
-
- Ahmed F, House RJ, and Feldman BH 2015. ‘Corneal Abrasions and Corneal Foreign Bodies’, Prim Care, 42: 363–75. - PubMed
-
- Araki-Sasaki K, Danjo S, Kawaguchi S, Hosohata J, and Tano Y 1997. ‘Human hepatocyte growth factor (HGF) in the aqueous humor’, Jpn J Ophthalmol, 41: 409–13. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
